64
Views
32
CrossRef citations to date
0
Altmetric
Drug Evaluation

Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis

, &
Pages 653-660 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Derya Algul, Alper Gokce, Ayberk Onal, Erkan Servet, Asiye Isın Dogan Ekici & Fatma Gulgun Yener. (2016) In vitro release and In vivo biocompatibility studies of biomimetic multilayered alginate-chitosan/β-TCP scaffold for osteochondral tissue. Journal of Biomaterials Science, Polymer Edition 27:5, pages 431-440.
Read now
Carmen Alvarez-Lorenzo, Emilio Bucio, Guillermina Burillo & Angel Concheiro. (2010) Medical devices modified at the surface by γ-ray grafting for drug loading and delivery. Expert Opinion on Drug Delivery 7:2, pages 173-185.
Read now

Articles from other publishers (30)

Amisha S. Raikar, Sushma Priya, Shilpa P. Bhilegaonkar, Sandesh N. Somnache & Deepak M. Kalaskar. (2023) Surface Engineering of Bioactive Coatings for Improved Stent Hemocompatibility: A Comprehensive Review. Materials 16:21, pages 6940.
Crossref
Jeon Min Kang, Song Hee Kim, Yeon Joo Choi, Yubeen Park, Dae Sung Ryu, Woo Seok Kang, Jung-Hoon Park & Hong Ju Park. (2022) Sirolimus-eluting cobalt–chrome alloy stent suppresses stent-induced tissue hyperplasia in a porcine Eustachian tube model. Scientific Reports 12:1.
Crossref
Neta Kutner, Konda Reddy Kunduru, Luna Rizik & Shady Farah. (2021) Recent Advances for Improving Functionality, Biocompatibility, and Longevity of Implantable Medical Devices and Deliverable Drug Delivery Systems. Advanced Functional Materials 31:44, pages 2010929.
Crossref
Daniela Arbeiter, Thomas Reske, Michael Teske, Dalibor Bajer, Volkmar Senz, Klaus-Peter Schmitz, Niels Grabow & Stefan Oschatz. (2021) Influence of Drug Incorporation on the Physico-Chemical Properties of Poly(l-Lactide) Implant Coating Matrices—A Systematic Study. Polymers 13:2, pages 292.
Crossref
Joanne O’Dwyer, Robert Wylie, Sally Ann Cryan, Garry P. Duffy & Eimear B. Dolan. 2020. Handbook of Biomaterials Biocompatibility. Handbook of Biomaterials Biocompatibility 573 599 .
Richard P. Tan, Alex H.P. Chan, Simon Wei, Miguel Santos, Bob S.L. Lee, Elysse C. Filipe, Behnam Akhavan, Marcela M. Bilek, Martin K.C. Ng, Yin Xiao & Steven G. Wise. (2019) Bioactive Materials Facilitating Targeted Local Modulation of Inflammation. JACC: Basic to Translational Science 4:1, pages 56-71.
Crossref
Nagavendra Kommineni, Raju Saka, Wahid Khan & Abraham J. Domb. (2017) Non-polymer drug-eluting coronary stents. Drug Delivery and Translational Research 8:4, pages 903-917.
Crossref
Tarek M. Bedair, Wooram Park, Bang-Ju Park, Myoung-Woon Moon, Kwang-Ryeol Lee, Yoon Ki Joung & Dong Keun Han. (2018) Dual-Layer Coated Drug-Eluting Stents with Improved Degradation Morphology and Controlled Drug Release. Macromolecular Research 26:7, pages 641-649.
Crossref
G.C. Alexander, P.T.J. Hwang, J. Chen, J. Kim, B.C. Brott, Y.S. Yoon & H.-W. Jun. (2017) Nanomatrix Coated Stent Enhances Endothelialization but Reduces Platelet, Smooth Muscle Cell, and Monocyte Adhesion under Physiologic Conditions. ACS Biomaterials Science & Engineering 4:1, pages 107-115.
Crossref
Tim D. Smith, Raji R. Nagalla, Esther Y. Chen & Wendy F. Liu. (2017) Harnessing macrophage plasticity for tissue regeneration. Advanced Drug Delivery Reviews 114, pages 193-205.
Crossref
So-Youn Lee, In-Ho Bae, Dae Sung Park, Eun-Jae Jang, Jae-Won Shim, Kyung-Seob Lim, Jun-Kyu Park, Doo Sun Sim & Myung Ho Jeong. (2016) Prednisolone- and sirolimus-eluting stent: Anti-inflammatory approach for inhibiting in-stent restenosis. Journal of Biomaterials Applications 31:1, pages 36-44.
Crossref
Michail Kastellorizios, Fotios Papadimitrakopoulos & Diane J. Burgess. (2015) Prevention of foreign body reaction in a pre-clinical large animal model. Journal of Controlled Release 202, pages 101-107.
Crossref
Jiang Zhang, Yang Liu, Rifang Luo, Si Chen, Xin Li, Shuheng Yuan, Jin Wang & Nan Huang. (2015) In vitro hemocompatibility and cytocompatibility of dexamethasone-eluting PLGA stent coatings. Applied Surface Science 328, pages 154-162.
Crossref
Geoffrey D. Keeler, Jeannine M. Durdik & Julie A. Stenken. (2015) Localized delivery of dexamethasone-21-phosphate via microdialysis implants in rat induces M(GC) macrophage polarization and alters CCL2 concentrations. Acta Biomaterialia 12, pages 11-20.
Crossref
Yae Min Park, Seung Hwan Han, Kyounghoon Lee, Soon Yong Suh, Pyung Chun Oh, Wook-Jin Chung, Woong Chol Kang, Kwang Kon Koh, Tae hoon Ahn, In Suk Choi & Eak Kyun Shin. (2013) Dexamethasone-eluting stents had sustained favorable ischemic driven target lesion revascularization rates over 5 years: A randomized controlled prospective study. International Journal of Cardiology 165:2, pages 359-362.
Crossref
Patrick W. F. Hadoke, Tiina Kipari, Jonathan R. Seckl & Karen E. Chapman. (2013) Modulation of 11β-Hydroxysteroid Dehydrogenase as a Strategy to Reduce Vascular Inflammation. Current Atherosclerosis Reports 15:5.
Crossref
Antonio Peramo. 2012. Integrated Biomaterials in Tissue Engineering. Integrated Biomaterials in Tissue Engineering 119 136 .
Chao-Yu Miao & Zhi-Yong Li. (2012) The role of perivascular adipose tissue in vascular smooth muscle cell growth. British Journal of Pharmacology 165:3, pages 643-658.
Crossref
Qing-Kui Guo, Zhi-Qian Lu, Jin-Ye Wang & Tao Li. (2011) In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis. Journal of Materials Science: Materials in Medicine 22:6, pages 1615-1623.
Crossref
S. Mourtas, M. Kastellorizios, P. Klepetsanis, E. Farsari, E. Amanatides, D. Mataras, B.R. Pistillo, P. Favia, E. Sardella, R. d’Agostino & S.G. Antimisiaris. (2011) Covalent immobilization of liposomes on plasma functionalized metallic surfaces. Colloids and Surfaces B: Biointerfaces 84:1, pages 214-220.
Crossref
L. E. Leigh Perkins. (2010) Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems. Veterinary Pathology 47:1, pages 58-76.
Crossref
R.M. Reynolds, B. Ilyas, J.F. Price, F.G.R. Fowkes, D.E. Newby, D.J. Webb & B.R. Walker. (2009) Circulating plasma cortisol concentrations are not associated with coronary artery disease or peripheral vascular disease. QJM 102:7, pages 469-475.
Crossref
Patrick W.F. Hadoke, Javaid Iqbal & Brian R. Walker. (2009) Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. British Journal of Pharmacology 156:5, pages 689-712.
Crossref
E. Deconinck, J. Sohier, I. De Scheerder & G. Van den Mooter. (2008) Pharmaceutical aspects of drug eluting stents. Journal of Pharmaceutical Sciences 97:12, pages 5047-5060.
Crossref
B.L. van der Hoeven, N.M.M. Pires, H.M. Warda, H. Putter, P.H.A. Quax, M.J. Schalij & J.W. Jukema. (2008) Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients. International Journal of Cardiology 124:2, pages 166-171.
Crossref
Ryan Berg, Joseph Aragon, Vladimir Royter, John F. Shanley, Greg Cogert, Renu Vermani, Saibal Kar, Neal Eigler & Frank Litvack. (2007) Pimecrolimus and dual pimecrolimus‐paclitaxel eluting stents decrease neointimal proliferation in a porcine model. Catheterization and Cardiovascular Interventions 70:6, pages 871-879.
Crossref
Santiago Jimenez‐Valero, Belen Santos, Fernando Pajin, Tomas Canton, Esther Lazaro, Jose Moreu, Gonzalo Hernandez & Luis Rodriguez Padial. (2007) Clinical outcomes of dexamethasone‐eluting stent implantation in ST‐elevation acute myocardial infarction. Catheterization and Cardiovascular Interventions 70:4, pages 492-497.
Crossref
Andreas König, Markus Leibig, Johannes Rieber, Thomas Michael Schiele, Karl Theisen, Uwe Siebert, Raffaella Matteucci Gothe & Volker Klauss. (2007) Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: Serial angiographic and sonographic analysis. American Heart Journal 153:6, pages 979.e1-979.e8.
Crossref
Ghanashyam Acharya & Kinam Park. (2006) Mechanisms of controlled drug release from drug-eluting stents. Advanced Drug Delivery Reviews 58:3, pages 387-401.
Crossref
Cherry L Wainwright. (2005) Targets for immunomodulation in cardiovascular disease – where are we now?. Future Cardiology 1:2, pages 177-189.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.